Hydroxychloroquine: The story of one drug during the COVID-19 pandemic

The new coronavirus (SARS-CoV-2) poses a serious threat to public health worldwide. From the moment of its finding to the present, the incidence of new cases is only increasing. So far, no drugs were proven to have antiviral activity in clinical practice. Many drugs have already gone a path from in vitro studies to randomized clinical trials in vivo. Objective. To review the literature on the use of hydroxychloroquine for the prevention and treatment of new coronavirus infection (COVID-19) for the period from the date of use until June 2020